Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery

NCT07532083 | Recruiting

• 4 other identifiers: 2025-1716UW25122SMPH/DOM Hemato Med OncProtocol Version 4/9/26
• Study Type: observational
• Target: 2,000
• Locations: 1 country
• Sites: 1

Brief Summary

The implementation of the AI-assisted radiology summary tool into clinical workflows is being conducted as part of a standard-of-care quality improvement (QI) initiative at UW Health. The evaluation of this tool's impact via structured feedback from patients and providers is being undertaken as a prospective research study.

Conditions

Oncology

Keywords

Patient Care; Patient Communication; AI; Artificial Intelligence; Radiology; Imaging; Summary Reports

Outcome Measures

Primary Outcomes (2)

• Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselves

  Baseline data collected in a 10-15 minute survey from patient participants pre-implementation and in a 10-15 minute survey from patient participants post-implementation.

  up to 15 minutes

• Perceived impact of scan-result-related patient queries on Provider Participant workload

  Scored from 1 (no impact) to 5 (very frequently), higher scores indicate higher impact on workload. Data collected at baseline (pre-implementation) and 3 months (post-implementation).

  baseline, 3 months

Other Outcomes (4)

• Proportion of Patient Participants who report that reviewing scans increases their anxiety

  up to 15 minutes

• Proportion of Patient Participants who report that they were "somewhat" or "very" satisfied with how scan results were shared and explained

  up to 15 minutes

• Proportion of Patient Participants who report that they "almost always" or "often" contact their provider to ask questions regarding their scan results prior to their follow-up visit

  up to 15 minutes

Study Arms (2)

Patient Participants

* Patient Baseline Survey (pre-implementation, at least 330 participants, up to 1900) * Patient Interviews (10-20 participants) * Patient Summary Feedback Survey (post-implementation, at least 330 participants, up to 1900)

Provider Participants

* Provider Surveys (baseline, 1 month and 3 month post-implementation, 60 participants) * Provider Interviews (up to 20 participants)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Cancer patients undergoing imaging studies as part of their routine clinical care at UW Health and providers who have access to the scan summary tool.

You may qualify if:

• Age 18 years or older
• Having a current or prior cancer diagnosis (any cancer type)
• Has active access to the UW Health MyChart patient portal.
• Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology.
• Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care.
• Willing and able to complete electronic REDCap surveys.
• For interview participation: willing to participate in a 30-45-minute phone or video interview.
• Faculty physician (MD or DO) practicing in the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology at UW Health.
• Involved in reviewing, discussing, or sharing imaging results with patients.
• Planned to gain access to the AI-assisted, patient-friendly imaging summary tool as part of clinical implementation.
• Willing and able to complete electronic surveys or participate in a brief interview (\~30 minutes).

You may not qualify if:

• Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team.
• Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligible.
• For the Patient Interview group only: Patients with radiographic disease progression will be excluded.

Sponsors & Collaborators

• University of Wisconsin, Madison: lead

Study Sites (1)

UW Health

Madison, Wisconsin, 53792, United States

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

• Hamid Emamekhoo, MD

  UW School of Medicine and Public Health

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Supportive Oncology

CONTACT

608-263-6002; supportiveoncology@uwcarbone.wisc.edu

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 8, 2026
• First Posted: April 15, 2026
• Study Start: February 1, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): January 1, 2027
• Last Updated: April 30, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)